Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 26, 2020 08:15 ET | Source: Aequus Pharmaceuticals

Aequus Announces Issuance of Stock Options

VANCOUVER, British Columbia, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
August 20, 2020 08:30 ET | Source: Aequus Pharmaceuticals

Aequus Announces New Chief Commercial Officer

VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
June 04, 2020 22:30 ET | Source: Aequus Pharmaceuticals

Aequus Announces Issuance of Stock Options

VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
June 01, 2020 15:12 ET | Source: Aequus Pharmaceuticals

Amendment on Earlier Release: Aequus Provides General Update and First Quarter 2020 Financial Highlights

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
June 01, 2020 09:15 ET | Source: Aequus Pharmaceuticals

Aequus Provides General Update and First Quarter 2020 Financial Highlights

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
April 29, 2020 21:00 ET | Source: Aequus Pharmaceuticals

Aequus Provides General Update and 2019 Financial Highlights

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
April 21, 2020 11:00 ET | Source: Aequus Pharmaceuticals

Aequus Announces Positive Update on Dry Eye Product Launch Plans

VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
March 23, 2020 08:45 ET | Source: Aequus Pharmaceuticals

A Message from the CEO of Aequus Pharmaceuticals

VANCOUVER, British Columbia, March 23, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
February 19, 2020 09:20 ET | Source: Aequus Pharmaceuticals

Aequus Announces Appointment of New Director to its Board & Stock Option Grant

VANCOUVER, British Columbia, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
February 03, 2020 09:15 ET | Source: Aequus Pharmaceuticals

Aequus and Medicom Announce Changes to their Respective Commercial Leadership Teams

VANCOUVER, British Columbia, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...